RE:RE:RE:MD&A is the same as the prospectus from Nov 15I really think the bought deal was perfectly timed. I don’t think they could have gotten a higher price for it, and for me the biggest risk in this stock has always been them running out of cash. This gives them two years to make things happen, flexibility, the ability to develop new products or acquire complementary ones. The common talking point by management is they want to go to market with the exact product their potential customers are asking for. I believe they have their eye on the long game, and they seem very prudent and meticulous to make sure they go to market with a product that will garner the most demand and gain the most traction.